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Geographically Indonesia is the largest archipelago country and the most populated no 4 in 
the world. After 72 years as indepence country then since 2014 started the National Health 
Coverage. Despite still many infectious disease, the non communicable and new emerging 
diseases still found. Indonesia had no exact data about Pulmonary Hypertension because of the 
lack participation of doctors and hospitals to joinour national registry: www.ina-registry.org.We 
are facing various obstacles. Some concerns that made Pulmonary Hypertension as Diagnostic 
and Treatment problem are (1)Poor knowledge about the etiology and pathophysiology of this 
abnormality. The etiology are varies but undetected congenital heart disease in the childhood 
then came at late stage (Grown Up Congenital Heart Disease) (2) Lack of Diagnostic and 
Treatment Facility ( Lung V/Q scan, RHC) (3) Limited Drug Coverability on National Health 
Insurance, (4) Expensive PH Drug Cost are the problems that must be solved to improve PH 
outcome. However, in the last six years there are signifi cant increases of referall case at PH 
clinic at our NCVC Jakarta. The need for PH Clinic / center with good fascilities and expert and 
generic PH medication is important. Early detection of congenital heart disease in neonates and 
children combined with pediatric surgery is mandatory. We should star the National Registry 
on PH and make PH clinic in big province hospital.
